Pancreatic Cancer Research

ResearcherPortland VA Medical CenterActive in the last 2 years

Leonidas G. Koniaris

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4864-6380; OpenAlex author ID A5046800626; NIH RePORTER profile ID 2053366. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
1
Labs led
1
Collaborators
27
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 4 papers, 1 grant

Papers 11

  1. Pancreatic Cancer Induces Population-Specific Switching of Myosin Isoforms and Discrete Activation of Cachexia Genes in Skeletal Muscle Myocytes Co-author DOI 10.1101/2025.09.01.673500↗
  2. Transcriptome and microRNAome profiling of human skeletal muscle in pancreatic cancer cachexia Co-author DOI 10.1101/2025.09.02.25334959↗
  3. Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Surviva… Co-author DOI 10.1200/jco-25-01631↗
  4. Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cac… Co-author DOI 10.1200/jco.23.01965↗
  5. Gemcitabine plus nab-paclitaxel preserves skeletal and cardiac mass and function in a murine model of pancreatic cancer cachexia Co-author DOI 10.1101/2023.04.15.536434↗
  6. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin. Co-author DOI 10.1002/jcsm.12998↗
  7. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. Co-author DOI 10.1084/jem.20190450↗
  8. Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways. Co-author DOI 10.3390/cancers13081975↗
  9. Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform. Co-author DOI 10.3390/cancers12123787↗
  10. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy. Co-author DOI 10.1002/jcsm.12461↗
  11. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer. Co-author DOI 10.1002/jcsm.12307↗

Grants 1

  1. Project 3 – Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC P01CA236778↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Teresa A Zimmers · 11 shared papers, 1 shared grant, 2018–2025 · strength 2.28
  2. Michael C. Ostrowski · 3 shared papers, 1 shared grant, 2025 · strength 1.24
  3. Ashok Narasimhan · 6 shared papers, 2020–2025 · strength 0.88
  4. Xiaoling Zhong · 5 shared papers, 2019–2025 · strength 0.73
  5. Denis C. Guttridge D · 3 shared papers, 2025 · strength 0.64
  6. Brittany R. Counts · 3 shared papers, 2023–2025 · strength 0.63
  7. Jian Ouyang · 1 shared grant, 2025 · strength 0.61
  8. Denis C Guttridge · 1 shared grant, 2025 · strength 0.61
  9. Martin John Romeo · 1 shared grant, 2025 · strength 0.61
  10. Safi Shahda · 5 shared papers, 2018–2022 · strength 0.53
  11. Yunlong Liu · 4 shared papers, 2019–2022 · strength 0.44
  12. Katherine R. Pelz · 2 shared papers, 2025 · strength 0.41
  13. Susann Theile · 2 shared papers, 2025 · strength 0.41
  14. Dorte Lisbet Nielsen · 2 shared papers, 2025 · strength 0.41
  15. Julia Sidenius Johansen · 2 shared papers, 2025 · strength 0.41
  16. Olav Faisal Dajani · 2 shared papers, 2025 · strength 0.41
  17. Inna Markovna Chen · 2 shared papers, 2025 · strength 0.41
  18. Joshua K. Kays · 3 shared papers, 2018–2021 · strength 0.30
  19. Daenique H. A. Jengelley · 2 shared papers, 2021–2023 · strength 0.26
  20. Joseph E. Rupert · 2 shared papers, 2021–2023 · strength 0.26
  21. Michael Garrett House · 2 shared papers, 2019–2021 · strength 0.18
  22. Nicholas Joseph Zyromski · 2 shared papers, 2019–2021 · strength 0.18
  23. Eugene P. Ceppa · 2 shared papers, 2019–2021 · strength 0.18
  24. Christian Max Schmidt · 2 shared papers, 2019–2021 · strength 0.18
  25. Melissa L. Fishel · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.